Beijing Strong Biotechnologies Inc
SZSE:300406

Watchlist Manager
Beijing Strong Biotechnologies Inc Logo
Beijing Strong Biotechnologies Inc
SZSE:300406
Watchlist
Price: 13.75 CNY 0.29% Market Closed
Market Cap: 8.1B CNY
Have any thoughts about
Beijing Strong Biotechnologies Inc?
Write Note

Beijing Strong Biotechnologies Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Beijing Strong Biotechnologies Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Strong Biotechnologies Inc
SZSE:300406
Cash & Cash Equivalents
ÂĄ1B
CAGR 3-Years
39%
CAGR 5-Years
16%
CAGR 10-Years
16%
Beigene Ltd
HKEX:6160
Cash & Cash Equivalents
ÂĄ15B
CAGR 3-Years
33%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash & Cash Equivalents
ÂĄ8.2B
CAGR 3-Years
22%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash & Cash Equivalents
ÂĄ3.8B
CAGR 3-Years
75%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash & Cash Equivalents
ÂĄ5.6B
CAGR 3-Years
3%
CAGR 5-Years
82%
CAGR 10-Years
19%
Imeik Technology Development Co Ltd
SZSE:300896
Cash & Cash Equivalents
ÂĄ2.4B
CAGR 3-Years
-11%
CAGR 5-Years
56%
CAGR 10-Years
N/A

See Also

What is Beijing Strong Biotechnologies Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
1B CNY

Based on the financial report for Jun 30, 2024, Beijing Strong Biotechnologies Inc's Cash & Cash Equivalents amounts to 1B CNY.

What is Beijing Strong Biotechnologies Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
16%

Over the last year, the Cash & Cash Equivalents growth was 250%. The average annual Cash & Cash Equivalents growth rates for Beijing Strong Biotechnologies Inc have been 39% over the past three years , 16% over the past five years , and 16% over the past ten years .

Back to Top